生技醫藥
NEW

從C肝藥捲土重來！泰宗轉戰泌尿道感染新藥 下一步怎麼走？  
生技醫藥
NEW

Alfasigma斥6.9億美元取GSK PBC搔癢藥授權

生技醫藥
NEW

美研究：黑人腎移植逆轉劣勢！eGFR種族係數移除奏效

GBI International
GBIHighlights

AI Revolutionizing Biomedicine: Recent Advances and Healthcare Applications

2023-12-01/GlobalBio & Investment
AIRevolutionizingBiomedicine:RecentAdvancesandHealthcareApplicationsAIanditsgenerativecapabilitieshavegainedsignificantattention,particularlyinthefieldofbiomedicine,sinceChatGPT'srisetoprominencei...
GBI International
GBIHighlights

Rebuilding Psychological Safety After Drug Allergy: A 4-Step Approach

2023-12-01/GlobalBio & Investment
RebuildingPsychologicalSafetyAfterDrugAllergy:A4-StepApproachAdrugallergyoccurswhentheimmunesystemreactstoanonprescription,prescription,orherbalmedicine.Patientssufferingfromdrugallergiesexperiencevar...
GBI International
GBIHighlights

LuminX Fluorescent Nano-Diamond Platform Achieves in Tracking Lung Injury, Head and Neck Cancer

2023-12-01/GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】LuminXFluorescentNano-DiamondPlatformAchievesinTrackingLungInjury,HeadandNeckCancer.TheinnovativetrackingplatformofLuminXcombinesnanoscal...
GBI International
GBIHighlights

EirGenix's Development Capacity Extends to CDMO and Biosimilars Across the US, Europe, and Taiwan

2023-12-01/GlobalBio & Investment
【Editor'sChoice|PreviewofSelectedCompaniesatBIOAsia-Taiwan】EirGenix'sDevelopmentCapacityExtendstoCDMOandBiosimilarsAcrosstheUS,Europe,andTaiwan. EirGenix(6589.TWO)isoneofthefewcompaniesinAsiat...
GBI International
GBIHighlights

Merck and Pythia Biotech Signed a MOU on Using Organ-on-Chip Technology to Develop...

2023-12-01/GlobalBio & Investment
MerckandPythiaBiotechSignedaMOUonUsingOrgan-on-ChipTechnologytoDevelopNext-GenerationPlatformforDrugTesting OnJune9, MerckKGaA,Darmstadt,Germany andTaiwanstartupPythiaBiotechsignedaMemorandumofUnderst...
GBI International
GBIHighlights

iXensor's CDMO New Business Model Accelerates Next-Generation At-Home Testing and...

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】iXensor'sCDMONewBusinessModelAcceleratesNext-GenerationAt-HomeTestingandPOCTProductDevelopment iXensor(6734.TWO),establishedin2012,istheworld'sfir...
GBI International
GBIHighlights

Hospitals in Taiwan use digital technology to implement medical care

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan’sMedicalDevice】Shortenunhealthylifeyears!HospitalsinTaiwanusedigitaltechnologytoimplementmedicalcare TheaveragelifeexpectancyofTaiwanesepeoplehasexceeded80years,butthe...
GBI International
GBIHighlights

Medical Taiwan Kicks Off on June 8!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】MedicalTaiwanKicksOffonJune8!230ExhibitorsandInternationalBuyersfrom60CountriesCreatingInfiniteBusinessesOpportunities MedicalTaiwan,hostedbytheTaiwanExte...
GBI International
GBIHighlights

Next Step: Targeting Neurological Disorders and Cancer Treatment?!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Storiesbehind #BIO2023】ModernaCo-founderandAlnylamSeniorVicePresident:WitnessingthePotentialofNucleicAcidTherapyinthePandemic!NextStep:TargetingNeurologicalDisordersandCancerTreatm...
GBI International
GBIHighlights

76-year-old CSD Successfully Transitions to B2C with Innovative 'Health in Style' Products.

2023-12-01/GlobalBio & Investment
【Editor'sChoice|Taiwan'sMedicalDevice】76-year-old #CSD SuccessfullyTransitionstoB2CwithInnovative'HealthinStyle'Products. CSD,aleadingbrandinTaiwanforhealthprotectionsupplieswitha76-ye...
GBI International
GBIHighlights

Taiwan Takes on Global Competition in National Genome Sequencing!

2023-12-01/GlobalBio & Investment
【Editor'sChoice|GenomeSequencing】TaiwanTakesonGlobalCompetitioninNationalGenomeSequencing!ExpertsUrgeGovernmenttoLeadinLarge-ScaleGenomeSequencingProgram. In1992,theHumanGenomeProjectwaslaunched,a...
GBI International
GBIHighlights

Genomics Raises 4.88 Million in Seasoned Equity Offering

2023-12-01/GlobalBio & Investment
【Editor'sChoice|GenomeSequencing】UpgradedManufacturingProcessesforDomesticNucleicAcidandPeptide!GenomicsRaises4.88MillioninSeasonedEquityOffering GenomicsBioSci&Tech(4195.TWO)recentlyannounced...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務